These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16258472)

  • 1. New therapies for mantle cell lyphoma.
    Williams ME
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):708, 11. PubMed ID: 16258472
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent progress in the therapeutic strategy for follicular lymphoma and mantle cell lymphoma].
    Ogura M
    Rinsho Ketsueki; 2006 Jun; 47(6):495-512. PubMed ID: 16862978
    [No Abstract]   [Full Text] [Related]  

  • 3. R-CHOP followed by consolidative autologous stem cell transplant and low dose rituxan maintenance therapy for advanced mantle cell lymphoma.
    Lim SH; Esler WV; Periman PO; Beggs D; Zhang Y; Townsend M
    Br J Haematol; 2008 Jul; 142(3):482-4. PubMed ID: 18510683
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen.
    Magni M; Di Nicola M; Carlo-Stella C; Matteucci P; Devizzi L; Tarella C; Benedetti F; Martelli M; Patti C; Parvis G; Rambaldi A; Barbui T; Gianni AM
    Bone Marrow Transplant; 2009 Mar; 43(6):509-11. PubMed ID: 18955979
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of mantle cell lymphoma: current approach and future directions.
    Brody J; Advani R
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):257-65. PubMed ID: 16751087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New data prove therapeutic superiority. MabThera in follicular and mantle cell lymphoma].
    Krankenpfl J; 2002; 40(5-6):161. PubMed ID: 12271501
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mantle cell lymphoma].
    Ogura M
    Rinsho Ketsueki; 2001 Apr; 42(4):281-7. PubMed ID: 11400298
    [No Abstract]   [Full Text] [Related]  

  • 8. Mantle cell lymphoma of the iris.
    Economou MA; Kopp ED; All-Ericsson C; Seregard S
    Acta Ophthalmol Scand; 2007 May; 85(3):341-3. PubMed ID: 17488468
    [No Abstract]   [Full Text] [Related]  

  • 9. Radioimmunotherapy in mantle cell lymphoma.
    Skarbnik AP; Smith MR
    Best Pract Res Clin Haematol; 2012 Jun; 25(2):201-10. PubMed ID: 22687456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the combination of rituximab and thalidomide influence the long-term perspectives of advanced-stage MCL?
    Lenz G; Dreyling M
    Nat Clin Pract Oncol; 2005 Feb; 2(2):72-3. PubMed ID: 16264875
    [No Abstract]   [Full Text] [Related]  

  • 11. Rituximab and DHAP followed by intensive therapy with autologous stem-cell transplantation as first-line therapy for mantle cell lymphoma.
    de Guibert S; Jaccard A; Bernard M; Turlure P; Bordessoule D; Lamy T
    Haematologica; 2006 Mar; 91(3):425-6. PubMed ID: 16531272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mantle-cell lymphoma (multiple lymphomatous polyposis) of the entire GI tract.
    Michopoulos S; Petraki K; Matsouka C; Kastritis E; Chrysanthopoulou H; Dimopoulos MA
    J Clin Oncol; 2008 Mar; 26(9):1555-7. PubMed ID: 18349408
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of focal segmental glomerulosclerosis in association with mantle cell lymphoma.
    Wong CF; Mohteshamzadeh M; Arsalanizadeh B; Dutt T; Shawki H; Khine MM; Rustom R
    Ren Fail; 2007; 29(3):363-6. PubMed ID: 17497453
    [No Abstract]   [Full Text] [Related]  

  • 14. [Maintenance therapy with rituximab].
    Krankenpfl J; 2005; 43(7-10):222-4. PubMed ID: 16515293
    [No Abstract]   [Full Text] [Related]  

  • 15. Syngeneic transplant in mantle cell lymphoma: a rare event and review of the literature.
    Engman CA; Hill JM; Meehan KR
    Clin Adv Hematol Oncol; 2009 May; 7(5):321-3. PubMed ID: 19521320
    [No Abstract]   [Full Text] [Related]  

  • 16. Unmet needs in the treatment of mantle cell lymphoma.
    Rosen ST; Link BK; Fowler NH
    Clin Adv Hematol Oncol; 2013 Nov; 11(11 Suppl 18):1-19. PubMed ID: 24893041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma.
    Ladetto M; Magni M; Pagliano G; De Marco F; Drandi D; Ricca I; Astolfi M; Matteucci P; Guidetti A; Mantoan B; Bodoni CL; Zanni M; Boccadoro M; Gianni AM; Tarella C
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1270-6. PubMed ID: 17162208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
    Wang M; Fayad L; Cabanillas F; Hagemeister F; McLaughlin P; Rodriguez MA; Kwak LW; Zhou Y; Kantarjian H; Romaguera J
    Cancer; 2008 Nov; 113(10):2734-41. PubMed ID: 18973182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma.
    Evens AM; Winter JN; Hou N; Nelson BP; Rademaker A; Patton D; Singhal S; Frankfurt O; Tallman MS; Rosen ST; Mehta J; Gordon LI
    Br J Haematol; 2008 Feb; 140(4):385-93. PubMed ID: 18162124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma.
    Robinson KS; Williams ME; van der Jagt RH; Cohen P; Herst JA; Tulpule A; Schwartzberg LS; Lemieux B; Cheson BD
    J Clin Oncol; 2008 Sep; 26(27):4473-9. PubMed ID: 18626004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.